Variant report
Variant | nsv433205 |
---|---|
Chromosome Location | chr2:141270270-141285694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116220759 | chr2:141282234-141282235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12616000 | chr2:141282257-141282258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs548096439 | chr2:141282277-141282278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116717620 | chr2:141282282-141282283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536831328 | chr2:141282283-141282284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186474761 | chr2:141282284-141282285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150376540 | chr2:141282306-141282307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538694850 | chr2:141282311-141282312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191401030 | chr2:141282317-141282318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572659907 | chr2:141282329-141282330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541676708 | chr2:141282331-141282332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561400408 | chr2:141282376-141282377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376036641 | chr2:141282401-141282402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575011365 | chr2:141282427-141282428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552534973 | chr2:141282435-141282436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374149706 | chr2:141282447-141282448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182432372 | chr2:141282448-141282449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563418588 | chr2:141282452-141282453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532196218 | chr2:141282458-141282459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552209506 | chr2:141282469-141282470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138032380 | chr2:141282479-141282480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528395368 | chr2:141282531-141282532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376864243 | chr2:141282549-141282550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186818253 | chr2:141282591-141282592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200852784 | chr2:141282603-141282604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550360149 | chr2:141282604-141282605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569820005 | chr2:141282680-141282681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149520125 | chr2:141282749-141282750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558696746 | chr2:141282752-141282753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115333834 | chr2:141282765-141282766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11891453 | chr2:141282801-141282802 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs528139887 | chr2:141282807-141282808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555283288 | chr2:141282816-141282817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546567412 | chr2:141282880-141282881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs11890379 | chr2:141282923-141282924 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs191240387 | chr2:141282933-141282934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557546664 | chr2:141282957-141282958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552415295 | chr2:141282970-141282971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183466404 | chr2:141282990-141282991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13404083 | chr2:141283401-141283402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs143896447 | chr2:141283416-141283417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs72973993 | chr2:141283425-141283426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568776928 | chr2:141283453-141283454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537703391 | chr2:141283462-141283463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557607735 | chr2:141283471-141283472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201766309 | chr2:141283472-141283473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143446090 | chr2:141283492-141283493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150122153 | chr2:141283532-141283533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199852537 | chr2:141283561-141283562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546068718 | chr2:141283572-141283573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141282200-141283000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr2:141283400-141284600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr2:141283800-141284200 | Enhancers | Gastric | stomach |